| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.0008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |